PATRICIA WAGNER: Open Payments
NPI 1306195078 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$845 in 43 payments from 11 companies in 2025. Trend: 2023 $748 · 2024 $1,020 · 2025 $845
Food & beverage: $845
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $214 |
| Novo Nordisk Inc | 9 | $195 |
| PFIZER INC. | 5 | $106 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $78 |
| Lilly USA, LLC | 4 | $67 |
| Abbott Laboratories | 2 | $49 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Dexcom, Inc. | 2 | $30 |
| Exact Sciences Corporation | 1 | $24 |
| Amgen Inc. | 1 | $19 |
Products named: JARDIANCE, FARXIGA, Rybelsus, PREVNAR 20, BREZTRI, AIRSUPRA, MOUNJARO, Wegovy.
Industry payments across NY — which companies pay providers there.
